Collectively, these observations suggest that miR-4256 suppresses p16INK4a expression to augment the malignant biological behavior of GC cells through the epigenetic modulation of HDAC5 at the p16INK4a promoter. The gene discussed is CDKN2A; the disease is gastric cancer.